{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:58:54Z","timestamp":1781179134642,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R44NS095423"],"award-info":[{"award-number":["R44NS095423"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["WO2017004205"],"award-info":[{"award-number":["WO2017004205"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["US2015011519"],"award-info":[{"award-number":["US2015011519"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["US9649320"],"award-info":[{"award-number":["US9649320"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["US2017027959"],"award-info":[{"award-number":["US2017027959"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["US2016060289"],"award-info":[{"award-number":["US2016060289"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["1U34AR068616"],"award-info":[{"award-number":["1U34AR068616"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["MDA353094"],"award-info":[{"award-number":["MDA353094"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["5U54HD090254"],"award-info":[{"award-number":["5U54HD090254"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"US Office of Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-15\\u20131-0265"],"award-info":[{"award-number":["W81XWH-15\\u20131-0265"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001625","name":"Foundation to Eradicate Duchenne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.steroids.2025.109721","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:41:19Z","timestamp":1763646079000},"page":"109721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exposure-response of serum biomarkers to vamorolone, a dissociative corticosteroidal anti-inflammatory drug, in 4- to &lt;7-year children"],"prefix":"10.1016","volume":"225","author":[{"given":"Swati","family":"Mummidivarpu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utkarsh J.","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ziemba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yetrib","family":"Hathout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula R.","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Damsker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Hagerty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Jusko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean K.","family":"Mah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Guglieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoram","family":"Nevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Kuntz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig M.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique M.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Finkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie S.","family":"Conklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"McCall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanneboyina","family":"Nagaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"van den Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6470-5139","authenticated-orcid":false,"given":"Eric P.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2025.109721_b0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1210\/rp.58.1.155","article-title":"Genomic analysis of corticosteroid-regulated promoters in murine T-lymphoma cells","volume":"58","author":"Chen","year":"2003","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.steroids.2025.109721_b0010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nsmb.2456","article-title":"The structural basis of direct corticosteroid-mediated transrepression","volume":"20","author":"Hudson","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.steroids.2025.109721_b0015","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1210\/me.2002-0106","article-title":"The corticosteroid receptor: coding a diversity of proteins and responses through a single gene","volume":"16","author":"Yudt","year":"2002","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.steroids.2025.109721_b0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.steroids.2025.109721_b0025","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.steroids.2025.109721_b0030","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40272-024-00655-5","article-title":"Efficacy and safety of vamorolone in duchenne muscular dystrophy: a systematic review","volume":"26","author":"Pascual-Morena","year":"2024","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.steroids.2025.109721_b0035","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/jamaneurol.2022.2480","article-title":"Efficacy and safety of vamorolone vs placebo and prednisone among boys with duchenne muscular dystrophy: a randomized clinical trial","volume":"79","author":"Guglieri","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.steroids.2025.109721_b0040","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000208112","article-title":"Efficacy and safety of vamorolone over 48 weeks in boys with duchenne muscular dystrophy: a randomized controlled trial","volume":"102","author":"Dang","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.steroids.2025.109721_b0045","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1093\/rheumatology\/keaf129","article-title":"Vamorolone: a novel metabolism resistant steroid that suppresses joint destruction in chronic polyarthritis with reduced systemic side effects","volume":"64","author":"Crastin","year":"2025","journal-title":"Rheumatology [oxford]."},{"key":"10.1016\/j.steroids.2025.109721_b0050","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201800186","article-title":"Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy","volume":"2","author":"Heier","year":"2019","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.steroids.2025.109721_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2025.109689","article-title":"Mineralocorticoid receptor antagonism of vamorolone: evidence from LIONHEART and VISION-DMD clinical trials","volume":"223","author":"de Vera","year":"2025","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2025.109721_b0060","doi-asserted-by":"crossref","first-page":"24285","DOI":"10.1073\/pnas.2006890117","article-title":"Disruption of a key ligand-H-bond network drives dissociative properties in vamorolone for Duchenne muscular dystrophy treatment","volume":"117","author":"Liu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.steroids.2025.109721_b0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1096\/fj.01-0245com","article-title":"Gene profiling reveals unknown enhancing and suppressive actions of corticosteroids on immune cells","volume":"16","author":"Galon","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.steroids.2025.109721_b0070","doi-asserted-by":"crossref","first-page":"15603","DOI":"10.1073\/pnas.0407008101","article-title":"Chromatin immunoprecipitation (ChIP) scanning identifies primary corticosteroid receptor target genes","volume":"101","author":"Wang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.steroids.2025.109721_b0075","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1371\/journal.pgen.0010016","article-title":"Glucocorticoid receptor-dependent gene regulatory networks","volume":"1","author":"Phuc Le","year":"2005","journal-title":"PLoS Genet."},{"key":"10.1016\/j.steroids.2025.109721_b0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10142-003-0090-x","article-title":"Gene arrays and temporal patterns of drug response: corticosteroid effects on rat liver","volume":"3","author":"Almon","year":"2003","journal-title":"Funct. Integr. Genomics"},{"key":"10.1016\/j.steroids.2025.109721_b0085","doi-asserted-by":"crossref","first-page":"E870","DOI":"10.1152\/ajpendo.00196.2005","article-title":"Corticosteroid-regulated genes in rat kidney: mining time series array data","volume":"289","author":"Almon","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2025.109721_b0090","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1465-9921-12-124","article-title":"Network analysis of quantitative proteomics on asthmatic bronchi: effects of inhaled corticosteroid treatment","volume":"12","author":"O'Neil","year":"2011","journal-title":"Respir. Res."},{"key":"10.1016\/j.steroids.2025.109721_b0095","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.phrs.2018.09.007","article-title":"Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug","volume":"136","author":"Conklin","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.steroids.2025.109721_b0100","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep4.1670","article-title":"SomaScan proteomics identifies serum biomarkers associated with liver fibrosis in patients with NASH","volume":"5","author":"Luo","year":"2021","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.steroids.2025.109721_b0105","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/SLA.0000000000003283","article-title":"Identification of plasma proteome signatures associated with surgery using SomaScan","volume":"273","author":"Fong","year":"2021","journal-title":"Ann. Surg."},{"key":"10.1016\/j.steroids.2025.109721_b0110","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.kint.2022.04.022","article-title":"Results of untargeted analysis using the SomaScan proteomics platform indicates novel associations of circulating proteins with risk of progression to kidney failure in diabetes","volume":"102","author":"Kobayashi","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.steroids.2025.109721_b0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/JAD-220399","article-title":"Comparative analysis of Alzheimer's disease cerebrospinal fluid biomarkers measurement by multiplex SomaScan platform and immunoassay-based approach","volume":"89","author":"Timsina","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.steroids.2025.109721_b0120","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.202100170","article-title":"Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SomaScan platforms","volume":"22","author":"Haslam","year":"2022","journal-title":"Proteomics"},{"key":"10.1016\/j.steroids.2025.109721_b0125","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1021\/acs.jproteome.4c00667","article-title":"Variability of 7K and 11K SomaScan plasma proteomics assays","volume":"23","author":"Candia","year":"2024","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.steroids.2025.109721_b0130","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1212\/WNL.0000000000008168","article-title":"Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function","volume":"93","author":"Hoffman","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.steroids.2025.109721_b0135","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.steroids.2025.109721_b0140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. Royal Statist. Soc. Ser. B"},{"key":"10.1016\/j.steroids.2025.109721_b0145","unstructured":"N. Pya, scam: Shape Constrained Additive Models. R package version 1.2-17, 2024, https:\/\/CRAN.R-project.org\/package=scam."},{"key":"10.1016\/j.steroids.2025.109721_b0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.steroids.2018.02.010","article-title":"Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes","volume":"134","author":"Hoffman","year":"2018","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2025.109721_b0155","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1210\/clinem\/dgae521","article-title":"Adrenal suppression from vamorolone and prednisone in Duchenne muscular dystrophy: results from the phase 2b clinical trial","volume":"110","author":"Ahmet","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2025.109721_b0160","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1084\/jem.147.6.1695","article-title":"Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functions","volume":"147","author":"Werb","year":"1978","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.steroids.2025.109721_b0165","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.4049\/jimmunol.169.9.5236","article-title":"Lymphotoxin-alpha-deficient mice make delayed, but effective, T and B cell responses to influenza","volume":"169","author":"Lund","year":"2002","journal-title":"J. Immun."},{"key":"10.1016\/j.steroids.2025.109721_b0170","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.steroids.2025.109721_b0175","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.steroids.2025.109721_b0180","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123390","article-title":"Disrupting the IL-36 and IL-23\/IL-17 loop underlies the efficacy of calcipotriol and corticosteroid therapy for psoriasis","volume":"4","author":"Germ\u00e1n","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.steroids.2025.109721_b0185","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.immuni.2020.02.004","article-title":"Structural Analysis reveals that the cytokine IL-17F forms a homodimeric complex with receptor IL-17RC to drive IL-17RA-independent signaling","volume":"52","author":"Goepfert","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.steroids.2025.109721_b0190","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1074\/jbc.M109372200","article-title":"Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer","volume":"277","author":"Haudenschild","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.steroids.2025.109721_b0195","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/j.asmr.2020.01.002","article-title":"Adverse impact of corticosteroids on rotator cuff tendon health and repair: a systematic review of basic science studies","volume":"2","author":"Puzzitiello","year":"2020","journal-title":"Arthrosc Sports Med Rehabil."},{"key":"10.1016\/j.steroids.2025.109721_b0200","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40264-015-0287-7","article-title":"Topical corticosteroid-induced skin atrophy: a comprehensive review","volume":"38","author":"Barnes","year":"2015","journal-title":"Drug Saf."},{"key":"10.1016\/j.steroids.2025.109721_b0205","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jamadermatol.2020.4968","article-title":"Association of potent and very potent topical corticosteroids and the risk of osteoporosis and major osteoporotic fractures","volume":"157","author":"Egeberg","year":"2021","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.steroids.2025.109721_b0210","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.ajpath.2010.12.053","article-title":"Spontaneous insertion of a b2 element in the ptpn6 gene drives a systemic autoinflammatory disease in mice resembling neutrophilic dermatosis in humans","volume":"178","author":"Nesterovitch","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.steroids.2025.109721_b0215","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nature12174","article-title":"RIP1-driven autoinflammation targets IL-1\u03b1 independently of inflammasomes and RIP3","volume":"498","author":"Lukens","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.steroids.2025.109721_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101958","article-title":"The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes","volume":"42","author":"Erusalimsky","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.steroids.2025.109721_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063871","article-title":"VBP15, a glucocorticoid analogue, is effective at reducing allergic lung inflammation in mice","volume":"8","author":"Damsker","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.steroids.2025.109721_b0230","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/emmm.201302621","article-title":"VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects","volume":"5","author":"Heier","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.steroids.2025.109721_b0235","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10571-014-0133-y","article-title":"VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis","volume":"35","author":"Dillingham","year":"2015","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.steroids.2025.109721_b0240","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00011-016-0956-8","article-title":"VBP15, a novel dissociative steroid compound, reduces NF\u03baB-induced expression of inflammatory cytokines in vitro and symptoms of murine trinitrobenzene sulfonic acid-induced colitis","volume":"65","author":"Damsker","year":"2016","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.steroids.2025.109721_b0245","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00011-019-01279-z","article-title":"Vamorolone, a dissociative steroidal compound, reduces collagen antibody-induced joint damage and inflammation when administered after disease onset","volume":"68","author":"Damsker","year":"2019","journal-title":"Inflamm. Res."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X2500162X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X2500162X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:17:44Z","timestamp":1781176664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X2500162X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":49,"alternative-id":["S0039128X2500162X"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2025.109721","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exposure-response of serum biomarkers to vamorolone, a dissociative corticosteroidal anti-inflammatory drug, in 4- to <7-year children","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2025.109721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109721"}}